colloidal Au and Ag nanoparticles
Overview
Colloidal gold (Au) and silver (Ag) nanoparticles are nanoscale suspensions of metallic particles, typically ranging from 1 to 100 nanometers in diameter, dispersed in an aqueous or organic medium. Their defining physicochemical property is localized surface plasmon resonance (LSPR), an optical phenomenon arising when incident light drives collective oscillations of conduction-band electrons at the particle surface. This resonance produces extraordinarily intense electromagnetic near-fields that underpin the technique known as surface-enhanced Raman scattering (SERS), in which analyte molecules adsorbed on or near the nanoparticle surface exhibit Raman signal enhancements of several orders of magnitude. Gold nanoparticles are prized for their chemical inertness, tunable optical properties, and straightforward surface functionalization, while silver nanoparticles offer even larger SERS enhancement factors and well-documented intrinsic antimicrobial activity attributable to the release of Ag⁺ ions and generation of reactive oxygen species that disrupt bacterial membranes and metabolic pathways.
Beyond their spectroscopic utility, Ag nanoparticles interact directly with biological systems: they impair cell-wall integrity in gram-positive and gram-negative bacteria, sensitize tumor cells to ionizing radiation, and can be incorporated into biomaterial scaffolds to confer sustained antibacterial protection. The dual functionality of colloidal Au and Ag nanoparticles—simultaneously serving as ultrasensitive analytical substrates and as bioactive agents—has made them central to a wide and rapidly expanding body of biomedical research spanning diagnostics, wound care, oncology, and bone regeneration.
Recent Publications Summary
Recent studies of colloidal silver nanoparticles have focused largely on green synthesis strategies and their use in antimicrobial and wound-healing applications. Multiple reports described biosynthesis or phytofabrication using plant extracts or biopolymers, including green tea extract, Stevia extract with soy soluble polysaccharides, tea polyphenol in a deacetylated sphingan matrix, Origanum majorana leaf extract, and Mikania micrantha leaf extract, as well as incorporation into electrospun or sponge-based biomaterials 42297939Jun42148914May42100849May41936968Apr41904914Mar42107094May42023956Apr. Across these studies, the nanoparticles were characterized by methods such as TEM, XRD, DLS, FTIR, and related physicochemical analyses, and were generally presented as stable, ecofriendly formulations intended to improve biocompatibility while retaining antimicrobial activity 42148914May42100849May41936968Apr42107094May.
Antibacterial effects were a consistent finding. Green-synthesized AgNPs showed strong activity against pathogens relevant to infected wounds and diabetic foot ulcers, including Pseudomonas aeruginosa, Escherichia coli, methicillin-resistant Staphylococcus aureus, Streptococcus pyogenes, Staphylococcus aureus, Bacillus cereus, Yersinia pestis, and Streptococcus enterica 42297939Jun41936968Apr41904914Mar. In the diabetic foot ulcer model study, AgNPs had the lowest MIC and MBC among the tested nanoparticle preparations and produced rapid killing with more than 10 log10 CFU/mL reduction within 2–6 hours 42297939Jun. Other work reported that AgNP-containing hydrogels and sponges were designed to provide sustained silver release and broad antibacterial coverage in infected wound settings 42100849May42023956Apr.
Several publications examined AgNPs in wound repair models, especially diabetic wounds. In a rat diabetic wound model, Stevia-derived, soy polysaccharide-coated AgNPs reduced wound area and increased collagen deposition, with the combination of AgNPs and Stevia extract performing better than either component alone 42148914May. A separate infected-wound hydrogel incorporating tea polyphenol and TP-capped AgNPs was developed to combine antibacterial, antioxidant, hemostatic, self-healing, and tissue-adhesive properties, with pH-responsive release of both tea polyphenol and silver 42100849May. Another bilayer polyurethane sponge used a silver nanoparticle-loaded upper layer together with a hydrophilic lower layer to support hemostasis, staged antibacterial action, and oxidative-stress control during full-cycle infected wound repair 42023956Apr. In a murine diabetic skin infection model, ecofriendly AgNPs were also investigated alongside ZnO nanoparticles and chitosan-tripolyphosphate nanoparticles as antibacterial candidates for healing effects 42297939Jun.
Beyond wound care, AgNPs were also studied in other biomedical contexts. In human glioblastoma cells, AgNPs induced cationic currents, increased intracellular calcium, depolarized the mitochondrial inner membrane, and promoted membrane blebbing; these effects were prevented by thiol reagents such as cysteine, suggesting that Ag+ was the active species mediating the response 42156577May. In a bone-regeneration scaffold, trace AgNP doping in polycaprolactone-silk fibroin electrospun nanofibers was used to balance osteogenic and antibacterial activity while maintaining cytocompatibility 42107094May. One study also reported catalytic activity of biogenic AgNPs for the construction of 2,4,5-triphenyl-1H-imidazole compounds, alongside antimicrobial testing and toxicity evaluation in Caco-2 human cancer cells 41904914Mar.
What Changes, What Holds
1. Green synthesis now dominates the recent silver-nanoparticle literature, but it mainly refines how these materials are made and packaged
METHOD These studies shift emphasis toward plant- and biopolymer-based fabrication, with standard physicochemical characterization used to argue for more ecofriendly, biocompatible formulations 42297939Jun42148914May. That changes the research workflow more than the biological account of colloidal Ag, which already included antimicrobial utility; the new work does not displace that baseline role.
2. Antibacterial potency remains the central functional claim, now extended to wound-relevant pathogens and rapid-kill settings
REINFORCES The new reports sharpen the established view that silver nanoparticles are intrinsically antimicrobial and useful in infected-wound contexts 42297939Jun41936968Apr. What is added is breadth and operational detail, not a new biological role: the same core activity is being confirmed against clinically relevant organisms and delivery formats.
3. silver nanoparticles are being positioned less as stand-alone antimicrobials and more as components of multifunctional wound-repair systems
NEW DIRECTION These studies extend the baseline’s wound-care use by coupling AgNPs with hemostatic, antioxidant, adhesive, self-healing, and sustained-release functions, while also reporting improved repair in diabetic models 42148914May42100849May. That does not contradict the established antibacterial and biomaterial roles, but it broadens the entity’s practical identity beyond simple antimicrobial protection.
4. silver nanoparticles now appear to have context-dependent cytotoxic and catalytic roles that sit outside the baseline biomedical narrative
NEW DIRECTION AgNP-induced ionic and mitochondrial effects in glioblastoma cells suggest a direct membrane/ion-mediated toxicity mechanism that is not discussed in the overview, which focuses on antimicrobial action, radiation sensitization, and scaffold use 42156577May. The bone-scaffold and catalytic findings further show that the recent literature is exploring AgNPs as tunable functional additives, not only as antibacterial agents 42107094May41904914Mar.
Overview update candidates: multifunctional wound-repair biomaterials; context-dependent cytotoxicity in glioblastoma cells; trace AgNP doping for bone-regeneration scaffolds.
colloidal au and ag nanoparticles
Background Contexts
In the literature, the biological baseline, pathological conditions, or disease models commonly surrounding colloidal au and ag nanoparticles are described as follows:
- alveolar bone regeneration (Biological Process) — 1 paper: PMIDs 42107094
- bacterial multiple drug resistance (Other) — 1 paper: PMIDs 42297939
- cardiovascular disease (Disease) — 1 paper: PMIDs 41740396
- diabetic wound (Disease) — 1 paper: PMIDs 42148914
- drug-resistant glioblastoma (Disease) — 1 paper: PMIDs 42156577
- full-thickness infected wounds (Disease) — 1 paper: PMIDs 42023956
- heart failure (Disease) — 1 paper: PMIDs 42240701
- overt diabetes (Disease) — 1 paper: PMIDs 42297939
- Raman Spectra (Other) — 1 paper: PMIDs 41985172
- sepsis (Clinical Metric) — 1 paper: PMIDs 41985172
Methodologies & Technologies Used
Researchers utilize the following experimental methods, imaging platforms, computational models, or biological reagents to study colloidal au and ag nanoparticles:
- Surface-enhanced Raman scattering (Technology) — 3 papers: PMIDs 42120743, 41985172, 41740396
- ACA (TRPM2 blocker) (Chemical) — 1 paper: PMIDs 42156577
- AgNPs-GTE loaded Cs-TPP-NPs combination (Therapy) — 1 paper: PMIDs 42297939
- antibacterial and bactericidal activity (Biological Process) — 1 paper: PMIDs 41936968
- Bombyx mori (Organism) — 1 paper: PMIDs 42107094
- Caco-2 intestinal cells (Cell Line) — 1 paper: PMIDs 41904914
- CD1 mouse model (Organism) — 1 paper: PMIDs 42297939
- Chitosan hydrogel (Other) — 1 paper: PMIDs 41935476
- deacetylated sphingan WL gum (Other) — 1 paper: PMIDs 42100849
- deep neural network model (Technology) — 1 paper: PMIDs 41985172
- DFT analysis (Technology) — 1 paper: PMIDs 41936968
- differential pulse voltammetry (Technology) — 1 paper: PMIDs 42240701
Molecular Interventions & Targets
The primary molecular pathways, regulatory genes, enzymes, or therapeutic agents actively targeted and manipulated in relation to colloidal au and ag nanoparticles include:
- Staphylococcus aureus (Organism) — 3 papers: PMIDs 42297939, 42100849, 41904914
- Pseudomonas aeruginosa (Organism) — 2 papers: PMIDs 42297939, 42100849
- 14 bacterial species (Organism) — 1 paper: PMIDs 41985172
- 2,4,5-triphenyl-1H-imidazole (Chemical) — 1 paper: PMIDs 41904914
- 4-mercaptobenzoic acid (Chemical) — 1 paper: PMIDs 41935476
- adenine (Chemical) — 1 paper: PMIDs 42120743
- adenosine triphosphate (Chemical) — 1 paper: PMIDs 42120743
- Bacillus cereus (Organism) — 1 paper: PMIDs 41904914
- chitosan-tripolyphosphate nanoparticles (Therapy) — 1 paper: PMIDs 42297939
- Chloride Ions (Chemical) — 1 paper: PMIDs 42240701
- cystic fibrosis transmembrane conductance regulator (Gene) — 1 paper: PMIDs 42240701
- elexacaftor/ivacaftor/tezacaftor (Therapy) — 1 paper: PMIDs 42240701
Observed Outcomes & Phenotypes
The phenotypic changes, physiological endpoints, or clinical metrics observed and measured in connection with colloidal au and ag nanoparticles include:
- biocompatibility (Other) — 2 papers: PMIDs 42100849, 41936968
- neovascularization (Biological Process) — 2 papers: PMIDs 42297939, 42023956
- wound closure (Clinical Metric) — 2 papers: PMIDs 42100849, 42023956
- 860 AM (Clinical Metric) — 1 paper: PMIDs 42120743
- acidic microenvironment (Biological Process) — 1 paper: PMIDs 42023956
- alkaline phosphatase activity (Clinical Metric) — 1 paper: PMIDs 42107094
- Antioxidant and anti-inflammatory properties (Biological Process) — 1 paper: PMIDs 41936968
- b-FGF (Gene) — 1 paper: PMIDs 42148914
- Bacterial membrane integrity (Biological Process) — 1 paper: PMIDs 42297939
- biofilm formation (Biological Process) — 1 paper: PMIDs 42297939
- blood components (Biological Process) — 1 paper: PMIDs 42023956
- calcium influx (Biological Process) — 1 paper: PMIDs 42156577
General Takeaways & Clinical Potentials
The high-level concepts, clinical translations, and overarching conclusions proposed in the research surrounding colloidal au and ag nanoparticles are summarized below:
- AI algorithms (Other) — 1 paper: PMIDs 41985172
- anticancer potential (Other) — 1 paper: PMIDs 41904914
- bacterial classification process (Other) — 1 paper: PMIDs 41985172
- controlled release characteristics (Other) — 1 paper: PMIDs 42100849
- effective management of infected wounds (Other) — 1 paper: PMIDs 42100849
- food safety monitoring (Other) — 1 paper: PMIDs 41935476
- Functional CFTR Evaluation (Other) — 1 paper: PMIDs 42240701
- green-synthesized multifunctional polysaccharide-based hydrogel (Other) — 1 paper: PMIDs 42100849
- infected bone defects (Other) — 1 paper: PMIDs 42107094
- infected diabetic wounds (Disease) — 1 paper: PMIDs 42148914
- integrated therapeutic strategy (Other) — 1 paper: PMIDs 42100849
- Next-Generation SERS Sensors (Other) — 1 paper: PMIDs 42120743